Suppr超能文献

70岁以上老年患者的肾移植:来自移植受者科学登记处的结果。

Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients.

作者信息

Rao Panduranga S, Merion Robert M, Ashby Valarie B, Port Friedrich K, Wolfe Robert A, Kayler Liise K

机构信息

Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109-0331, USA.

出版信息

Transplantation. 2007 Apr 27;83(8):1069-74. doi: 10.1097/01.tp.0000259621.56861.31.

Abstract

BACKGROUND

Elderly patients (ages 70 yr and older) are among the fastest-growing group starting renal-replacement therapy in the United States. The outcomes of elderly patients who receive a kidney transplant have not been well studied compared with those of their peers on the waiting list.

METHODS

Using the Scientific Registry of Transplant Recipients, we analyzed data from 5667 elderly renal transplant candidates who initially were wait-listed from January 1, 1990 to December 31, 2004. Of these candidates, 2078 received a deceased donor transplant, and 360 received a living donor transplant by 31 December 2005. Time-to-death was studied using Cox regression models with transplant as a time-dependent covariate. Mortality hazard ratios (RRs) of transplant versus waiting list were adjusted for recipient age, sex, race, ethnicity, blood type, panel reactive antibody, year of placement on the waiting list, dialysis modality, comorbidities, donation service area, and time from first dialysis to first placement on the waiting list.

RESULTS

Elderly transplant recipients had a 41% lower overall risk of death compared with wait-listed candidates (RR=0.59; P<0.0001). Recipients of nonstandard, that is, expanded criteria donor, kidneys also had a significantly lower mortality risk (RR=0.75; P<0.0001). Elderly patients with diabetes and those with hypertension as a cause of end-stage renal disease also experienced a large benefit.

CONCLUSIONS

Transplantation offers a significant reduction in mortality compared with dialysis in the wait-listed elderly population with end-stage renal disease.

摘要

背景

在美国,老年患者(70岁及以上)是开始接受肾脏替代治疗人数增长最快的群体之一。与等待名单上的同龄人相比,接受肾移植的老年患者的治疗效果尚未得到充分研究。

方法

我们使用移植受者科学注册系统,分析了1990年1月1日至2004年12月31日最初被列入等待名单的5667名老年肾移植候选人的数据。在这些候选人中,到2005年12月31日,有2078人接受了尸体供体移植,360人接受了活体供体移植。使用Cox回归模型研究死亡时间,将移植作为时间依赖性协变量。根据受者年龄、性别、种族、民族、血型、群体反应性抗体、列入等待名单的年份、透析方式、合并症、捐赠服务区以及从首次透析到首次列入等待名单的时间,对移植与等待名单的死亡风险比(RRs)进行调整。

结果

与列入等待名单的候选人相比,老年移植受者的总体死亡风险降低了41%(RR=0.59;P<0.0001)。接受非标准(即扩大标准供体)肾脏移植的受者的死亡风险也显著降低(RR=0.75;P<0.0001)。患有糖尿病的老年患者以及因高血压导致终末期肾病的患者也受益匪浅。

结论

对于列入等待名单的患有终末期肾病的老年人群体,与透析相比,移植可显著降低死亡率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验